Last reviewed · How we verify
NCT04767737
The Effect of Aromatherapy on the Insulin Injection Pain
NA trial testing Topically Administered Lavender Aromatherapy in Pain in 180 participants. Completed in 31 July 2020.
31 May 2020
Quick facts
| Lead sponsor | Karadeniz Technical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 180 |
| Start date | 1 May 2020 |
| Primary completion | 31 May 2020 |
| Estimated completion | 31 July 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Topically Administered Lavender Aromatherapy
- Topically Administered Water
Conditions studied
- Pain — all drugs for Pain →
- Aromatherapy — all drugs for Aromatherapy →
- Subcutaneous Injections — all drugs for Subcutaneous Injections →
Sponsor
Karadeniz Technical University
Who can join
18 and older, any sex, with Pain or Aromatherapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Needle phobia occurs in more than half of diabetic patients due to the pain caused by frequent insulin injection. Therefore, this study evaluated the effect of topically administered lavender aromatherapy on the pain of insulin injection in diabetic patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The effect of topically administered lavender aromatherapy on the pain of insulin injection in diabetic patients: a double-blind randomized controlled clinical trial.
Demirağ H, Hintistan S, Bulut E. · · 2022 · cited 5× · PMID 36945997 · DOI 10.55730/1300-0144.5531
Verify or expand the search:
- PubMed search for NCT04767737
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pain
Currently open trials in the same condition.
- NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
- NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
- NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting
Other Karadeniz Technical University trials
Trials by the same sponsor.
- NCT07526779 — Motivational Interviewing on Loneliness Level, Activities of Daily Living, and Quality of Life in Elderly · NA · not yet recruiting
- NCT07448168 — Effect of Standardized Patient Simulation on Nursing Students' Assessment, Diagnosis Skills, and Experiences · NA · not yet recruiting
- NCT07435233 — Different Reality Simulation Education Methods on Nursing Students · NA · active not recruiting
- NCT07238348 — Analgesic Effectiveness of SPSIPB Versus Thoracic Epidural and Systemic Opioid Analgesia After VATS (SPSIPB-VATS) · not yet recruiting
- NCT07297498 — The Effect of Simulation-based Education Within the Framework of the Clinical Judgment Model on Nursing Students' Clinic · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04767737 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karadeniz Technical University
- Last refreshed: 23 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04767737.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing